BRIEF published on 02/17/2026 at 14:32, 16 days 1 hour ago Threshold Crossing by Deep Track Biotechnology Voting Rights Actions Threshold Crossing Inventiva Deep Track
BRIEF published on 02/17/2026 at 08:35, 16 days 7 hours ago Inventiva announces its preliminary financial results for 2025 Financial Results Treasury Biopharmaceutical Public Offering Inventiva
BRIEF published on 02/17/2026 at 08:35, 16 days 7 hours ago Inventiva Reports Preliminary Financial Results for 2025 Financial Results Cash Flow Biopharmaceuticals Inventiva MASH
PRESS RELEASE published on 02/17/2026 at 08:30, 16 days 7 hours ago Inventiva reports preliminary 2025¹ fiscal year financial results Inventiva reports preliminary 2025 fiscal year financial results, showing €99.3 million in cash, €131.6 million in short-term deposits, and €4.5 million in revenues Revenues Financial Results Clinical-stage Inventiva Cash Equivalents
BRIEF published on 02/04/2026 at 22:05, 1 month ago Inventiva at the Guggenheim Biotech Summit 2026 New York Inventiva MASH Lanifibranor Biotech Summit
BRIEF published on 02/04/2026 at 22:05, 1 month ago Inventiva to Participate in Guggenheim Biotech Summit 2026 Biopharmaceuticals Inventiva MASH Lanifibranor Biotech Summit
PRESS RELEASE published on 02/04/2026 at 22:00, 1 month ago Inventiva to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 Inventiva to present at Guggenheim Emerging Outlook: Biotech Summit 2026. CEO Andrew Obenshain to participate in fireside chat on February 11, 2026, in New York City Fireside Chat Inventiva Biotech Summit Guggenheim Emerging Outlook CEO Andrew Obenshain
BRIEF published on 01/30/2026 at 11:21, 1 month 6 days ago JP Morgan Chase & Co.'s reduced stake in INVENTIVA Shares Threshold Crossing Right To Vote JP Morgan Inventiva
BRIEF published on 01/26/2026 at 22:05, 1 month 9 days ago Inventiva's Liquidity Contract with Kepler Cheuvreux: Half-Year Update Liquidity Contract Kepler Cheuvreux Biopharmaceutical Inventiva MASH
PRESS RELEASE published on 01/26/2026 at 22:00, 1 month 9 days ago Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux Inventiva's half-year review of liquidity contract with Kepler Cheuvreux reveals cash & share details as of Dec 2025, showing increase from previous report Liquidity Contract Kepler Cheuvreux Financial Report Biopharmaceutical Inventiva
Published on 03/05/2026 at 14:00, 1 hour 45 minutes ago EQ Inc. Secures Strategic Partnership with Global Card Network to Expand Integrated Rewards Across Canada
Published on 03/05/2026 at 14:00, 1 hour 45 minutes ago GameSquare's Stream Hatchet Publishes 2025 YouTube Gaming Trends Report
Published on 03/05/2026 at 14:00, 1 hour 45 minutes ago Horizon Aircraft's Unique VTOL Delivers Up to 75% Lower Operating Costs Than Helicopters
Published on 03/05/2026 at 13:40, 2 hours 5 minutes ago Lobe Sciences Ltd. Announces Presence in Miami During the Jefferies and Leerink Healthcare Conferences
Published on 03/05/2026 at 13:30, 2 hours 15 minutes ago Vox Royalty Provides 2026 Guidance and Increases Quarterly Dividend
Published on 03/05/2026 at 15:32, 13 minutes ago Correction of a release from 31.12.2025 07:30 GMT/BST - Restoration- daVictus Plc
Published on 03/05/2026 at 15:06, 39 minutes ago Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The
Published on 03/04/2026 at 23:50, 15 hours 55 minutes ago Total number of voting rights and shares making up the share capital at February 28, 2026
Published on 03/04/2026 at 18:00, 21 hours 45 minutes ago Disclosure of Share Capital and Voting Rights as of February 28, 2026
Published on 03/04/2026 at 17:45, 22 hours ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
